Headlands Technologies LLC Takes $54,000 Position in Atrion Co. (NASDAQ:ATRI)

Headlands Technologies LLC bought a new stake in Atrion Co. (NASDAQ:ATRI) during the second quarter, according to its most recent disclosure with the SEC. The institutional investor bought 119 shares of the medical instruments supplier’s stock, valued at approximately $54,000.

Other hedge funds have also bought and sold shares of the company. Penn Mutual Asset Management LLC acquired a new stake in shares of Atrion in the fourth quarter valued at approximately $1,949,000. Public Employees Retirement System of Ohio acquired a new stake in Atrion during the 1st quarter valued at $2,299,000. Jump Financial LLC bought a new position in Atrion during the fourth quarter worth $234,000. Sei Investments Co. increased its holdings in shares of Atrion by 59.7% in the first quarter. Sei Investments Co. now owns 1,774 shares of the medical instruments supplier’s stock valued at $822,000 after purchasing an additional 663 shares during the last quarter. Finally, Quadrant Capital Group LLC bought a new position in shares of Atrion in the fourth quarter valued at about $36,000. 66.19% of the stock is currently owned by institutional investors and hedge funds.

Analysts Set New Price Targets

Separately, StockNews.com began coverage on shares of Atrion in a research note on Wednesday, September 11th. They issued a “sell” rating on the stock.

Atrion Stock Performance

Shares of NASDAQ ATRI opened at $459.92 on Tuesday. The firm has a market cap of $809.46 million, a P/E ratio of 43.23 and a beta of 0.69. The business’s 50 day moving average is $458.42 and its 200-day moving average is $443.19. Atrion Co. has a 1-year low of $274.98 and a 1-year high of $503.24.

Atrion (NASDAQ:ATRI) last posted its earnings results on Thursday, August 8th. The medical instruments supplier reported $0.23 earnings per share for the quarter. The company had revenue of $48.77 million during the quarter. Atrion had a return on equity of 7.75% and a net margin of 10.60%.

Atrion Company Profile

Atrion Corporation, together with its subsidiaries, develops, manufactures, and sells products for fluid delivery, cardiovascular, and ophthalmic applications in the United States, Canada, Europe, and internationally. The company's fluid delivery products include valves that fill, hold, and release controlled amounts of fluids or gasses for use in various intubation, intravenous, catheter, and other applications in the anesthesia and oncology fields, as well as promote infection control in hospital and home healthcare environments.